Literature DB >> 12951545

Concurrent infections that rise the HIV viral load.

Zvi Bentwich1.   

Abstract

A common denominator of all the major infections found concurrently with HIV is immune activation. Though the type and characteristics of this activation differ among the various infections, the result is invariably increased HIV infection and replication. Furthermore, the immune activation may affect other concurrent infections such as tuberculosis. Therefore, eradication or suppression of concurrent infections in HIV-infected people may have a major impact on the spread and progression of HIV infection and AIDS, and also on protective HIV vaccines. This applies particularly to developing countries, where these infections are common and no antiretroviral therapy is available. Further studies are urgently needed to clarify and further characterise the long-term effects of concurrent infections on the spread and progression of HIV/AIDS, and particularly on the immune response of the infected host.

Entities:  

Mesh:

Year:  2003        PMID: 12951545

Source DB:  PubMed          Journal:  J HIV Ther        ISSN: 1462-0308


  16 in total

Review 1.  Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression.

Authors:  Kayvon Modjarrad; Eric Chamot; Sten H Vermund
Journal:  AIDS       Date:  2008-10-18       Impact factor: 4.177

2.  Assessment of CD8 T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Côte d'Ivoire.

Authors:  P Ondoa; S Koblavi-Dème; M-Y Borget; M L Nolan; J N Nkengasong; L Kestens
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 3.  Effect of treating co-infections on HIV-1 viral load: a systematic review.

Authors:  Kayvon Modjarrad; Sten H Vermund
Journal:  Lancet Infect Dis       Date:  2010-07       Impact factor: 25.071

4.  Host cytokine production, lymphoproliferation, and antibody responses during the course of Ancylostoma ceylanicum infection in the Golden Syrian hamster.

Authors:  Susana Mendez; Jesus G Valenzuela; Wenhui Wu; Peter J Hotez
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 5.  Clinically relevant drug-drug interactions between antiretrovirals and antifungals.

Authors:  Ramya Krishna Vadlapatla; Mitesh Patel; Durga K Paturi; Dhananjay Pal; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-02-12       Impact factor: 4.481

6.  Human immunodeficiency virus and leishmaniasis.

Authors:  Navid Ezra; Maria Teresa Ochoa; Noah Craft
Journal:  J Glob Infect Dis       Date:  2010-09

7.  Coinfection with Schistosoma mansoni reactivates viremia in rhesus macaques with chronic simian-human immunodeficiency virus clade C infection.

Authors:  Mila Ayash-Rashkovsky; Agnès-Laurence Chenine; Lisa N Steele; Sandra J Lee; Ruijiang Song; Helena Ong; Robert A Rasmussen; Regina Hofmann-Lehmann; James G Else; Peter Augostini; Harold M McClure; W Evan Secor; Ruth M Ruprecht
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

Review 8.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 9.  The immunology of Leishmania/HIV co-infection.

Authors:  Ifeoma Okwor; Jude Eze Uzonna
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

10.  Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection.

Authors:  David J Mock; Joseph A Hollenbaugh; Waaqo Daddacha; Michael G Overstreet; Chris A Lazarski; Deborah J Fowell; Baek Kim
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.